SI1591445T1 - Priprava kabergolina oblike I in njegovega solvata - Google Patents

Priprava kabergolina oblike I in njegovega solvata

Info

Publication number
SI1591445T1
SI1591445T1 SI200530276T SI200530276T SI1591445T1 SI 1591445 T1 SI1591445 T1 SI 1591445T1 SI 200530276 T SI200530276 T SI 200530276T SI 200530276 T SI200530276 T SI 200530276T SI 1591445 T1 SI1591445 T1 SI 1591445T1
Authority
SI
Slovenia
Prior art keywords
cabergoline
solvate
preparation
cabergoline form
solvent
Prior art date
Application number
SI200530276T
Other languages
English (en)
Inventor
Alan Greenwood
Derek Mchattie
Parveen Bhatarah
Mark Gamble
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32482531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1591445(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of SI1591445T1 publication Critical patent/SI1591445T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Secondary Cells (AREA)
SI200530276T 2004-04-30 2005-04-29 Priprava kabergolina oblike I in njegovega solvata SI1591445T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409785.3A GB0409785D0 (en) 2004-04-30 2004-04-30 Preparation of cabergoline
EP05252709A EP1591445B1 (en) 2004-04-30 2005-04-29 Preparation of cabergoline form I und solvate thereof

Publications (1)

Publication Number Publication Date
SI1591445T1 true SI1591445T1 (sl) 2008-08-31

Family

ID=32482531

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530276T SI1591445T1 (sl) 2004-04-30 2005-04-29 Priprava kabergolina oblike I in njegovega solvata

Country Status (18)

Country Link
US (1) US7186837B2 (sl)
EP (1) EP1591445B1 (sl)
JP (1) JP2007535526A (sl)
AT (1) ATE394397T1 (sl)
AU (1) AU2005238276B2 (sl)
CA (1) CA2565440C (sl)
CY (1) CY1108244T1 (sl)
DE (1) DE602005006465D1 (sl)
DK (1) DK1591445T3 (sl)
ES (1) ES2304670T3 (sl)
GB (1) GB0409785D0 (sl)
HR (1) HRP20080292T3 (sl)
NZ (1) NZ550925A (sl)
PL (1) PL1591445T3 (sl)
PT (1) PT1591445E (sl)
RS (1) RS50655B (sl)
SI (1) SI1591445T1 (sl)
WO (1) WO2005105796A1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60236600D1 (de) 2001-08-13 2010-07-15 Du Pont Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
US7531551B2 (en) * 2003-05-08 2009-05-12 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
EP1953157A1 (en) 2007-01-31 2008-08-06 LEK Pharmaceuticals D.D. New crystal form of cabergoline

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH535236A (de) 1970-06-19 1973-03-31 Sandoz Ag Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate
CH535235A (de) 1970-06-19 1973-03-31 Sandoz Ag Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
PH11140A (en) 1973-11-28 1977-10-27 Lilly Co Eli D-6-alkyl-2,8-disubstituted ergolines and a process for inhibiting the secretion of prolactin in mammals
CH587858A5 (sl) * 1973-11-28 1977-05-13 Sandoz Ag
DE2525962A1 (de) 1974-06-21 1976-01-08 Sandoz Ag Neue heterocyclische verbindungen, ihre herstellung und verwendung
US4166182A (en) 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4180582A (en) * 1978-02-08 1979-12-25 Eli Lilly And Company 6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
NL189462C (nl) 1980-04-03 1993-04-16 Erba Carlo Spa Ergolinederivaten met antiprolactinische en/of antihypertensieve eigenschappen en farmaceutische preparaat daarvan.
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
AU553809B2 (en) * 1981-07-21 1986-07-31 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
GB2103603B (en) 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
GB9205439D0 (en) * 1992-03-12 1992-04-22 Erba Carlo Spa Process for the synthesis of ergoline derivatives
CZ287176B6 (cs) 1997-10-03 2000-10-11 Galena A. S. Způsob přípravy ergolinových derivátů
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
GB0007307D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form || of cabergoline
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
GB0007309D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form V|| of cabergoline
AU2003218753A1 (en) 2002-03-15 2003-09-29 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
PL372371A1 (en) 2002-03-15 2005-07-25 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
US7531551B2 (en) * 2003-05-08 2009-05-12 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline

Also Published As

Publication number Publication date
PT1591445E (pt) 2008-06-02
ES2304670T3 (es) 2008-10-16
DK1591445T3 (da) 2008-08-11
GB0409785D0 (en) 2004-06-09
RS50655B (sr) 2010-06-30
US7186837B2 (en) 2007-03-06
JP2007535526A (ja) 2007-12-06
EP1591445A1 (en) 2005-11-02
EP1591445B1 (en) 2008-05-07
WO2005105796A1 (en) 2005-11-10
AU2005238276B2 (en) 2011-08-18
ATE394397T1 (de) 2008-05-15
PL1591445T3 (pl) 2008-09-30
US20050245560A1 (en) 2005-11-03
HRP20080292T3 (en) 2008-07-31
CA2565440A1 (en) 2005-11-10
AU2005238276A1 (en) 2005-11-10
DE602005006465D1 (de) 2008-06-19
CY1108244T1 (el) 2014-02-12
CA2565440C (en) 2011-09-20
NZ550925A (en) 2010-02-26

Similar Documents

Publication Publication Date Title
HRP20080292T3 (en) Preparation of cabergoline form i and solvate thereof
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
HK1112238A1 (en) Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
TW200730518A (en) Crystalline forms of docetaxel and processes for their preparation
WO2007136510A3 (en) Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
TW200613243A (en) Novel compounds
NZ552137A (en) New 4-benzylidene-piperidin derivatives
TW200732340A (en) Novel forms of tiotropium bromide and processes for preparation thereof
MX2007006374A (es) Derivados del 5-hidroxi-benzotiazol que tienen actividad agonista del adrenoreceptor-beta-2.
WO2006011050A3 (en) Pyridine derivatives
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
MY144050A (en) Tetralin and indane derivatives and uses thereof
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
MX2010003495A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas.
WO2006127815A3 (en) Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
PL1831191T3 (pl) Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT
TW200607810A (en) Process to prepare camptothecin derivatives
GB0523435D0 (en) Process
WO2006029210A3 (en) Acyclic 1,3-diamines and uses therefor
HK1126791A1 (en) Process for the manufacture of lysobactin derivatives
MXPA04008935A (es) Procedimiento para la preparacion de la forma i cristalina de la cabergolina.
MX2010011767A (es) Derivados de benzocicloheptano y benzoxepina.
MX2007007485A (es) Derivados de cromano y usos de los mismos en el tratamiento de trastornos del sistema nervioso central.
MX2007003159A (es) Derivados piridinicos de indolin-2-ona, prepracion y uso terapeutico de los mismos.